Crossmark

C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer

Crossref DOI link: https://doi.org/10.1136/jitc-2021-004024

Published Online: 2022-03-15

Published Print: 2022-03

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Klümper, Niklas

Saal, Jonas

Berner, Fiamma

Lichtensteiger, Christa https://orcid.org/0000-0002-9478-0639
Wyss, Nina

Heine, Annkristin

Bauernfeind, Franz Georg

Ellinger, Jörg

Brossart, Peter

Diem, Stefan

Schmid, Sabine

Joerger, Markus

Frueh, Martin

Ritter, Manuel

Hölzel, Michael https://orcid.org/0000-0003-4048-8824
Flatz, Lukas

Bald, Tobias https://orcid.org/0000-0003-0061-235X
Funding

Funding for this research was provided by:

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PP00P3_157448)

Deutsche Forschungsgemeinschaft (Germany’s Excellence Strategy – EXC2151–3908)

Deutsche Gesellschaft für Urologie (KIN1/FE-19)

Rheinische Friedrich-Wilhelms-Universität Bonn (2020-2A-12)
License Information

License valid from 2022-03-14